The SUM-229PE cell line was derived from a small pleural effusion specimen that came to the lab. The resulting cell line is a classic triple negative breast cancer cell line of the basal subtype. And, like many such cell lines, these cells have a KRAS point mutation, a common TP53 mutation and they overexpress MYC at the mRNA level.
Okay, let’s delve more deeply into the SUM-229 cell line.
- Derivation of the SUM-229 cell line
- Narrative Summary of the SUM-229 cell line
- Genomic alterations of the SUM-229 cell line
- The KEGG canonical pathways enriched with data from our genome-scale shRNA screen
- Functional-druggable signature for SUM-229 cells
- Bibliography of published papers in which SUM-229 cells were used
- SUM-229 Blog
Back to the SUM cell line Gateway Page
